Nuveen Investment Trust III has recently filed its NPORT-P report, providing insights into its asset management and financial health. The filing, dated October 29, 2026, indicates that the trust manages a total net asset value of approximately $2.12 billion. This significant figure underscores the trust's position in the investment management industry and highlights its ongoing operations amidst evolving market conditions.
The filing reveals that the trust's total assets amount to $2,222,695,592, with liabilities totaling $93,795,666, resulting in net assets of $2,128,899,926. This financial snapshot is crucial for stakeholders, including investors and analysts, as it reflects the trust's ability to manage and grow its assets effectively.
Background
Nuveen Investment Trust III is an investment entity incorporated in Massachusetts. The trust operates under the SEC Act of 1940 and is registered with the SEC under file number 811-09037. The trust's primary focus is on managing various investment funds, including the Nuveen Floating Rate Income Fund. The trust's business address is located at 333 West Wacker Drive, Chicago, Illinois.
What the Filing Says
The recent filing provides a comprehensive overview of the trust's financial standing as of August 31, 2026. It states, "The total assets are reported at $2,222,695,592, with net assets amounting to $2,128,899,926." This information is vital for understanding the trust's performance in the competitive investment landscape.
Impact
This filing may affect various stakeholders, including investors looking for insights into the trust's asset management capabilities. Additionally, competitors in the investment management sector will likely analyze these figures to benchmark their performance and strategize accordingly.
What's Next
The filing does not say what happens next.
Read Next
Kinney Virginia reports stock transaction in NRG Energy
Fitzgerald Scott Michael reports share transaction at StubHub
Baker Eric Howard Acquires 18,130 Shares of StubHub Holdings
Hart Scott Barton Acquires Shares in NRG Energy, Inc.
Arcutis Biotherapeutics reports stock ownership update
Jazz Pharmaceuticals Director Sells 6,000 Shares in Transaction





